The ERC-funded Obenauf Group at the Research Institute of Molecular Pathology (IMP), in collaboration with Boehringer Ingelheim (BI) in Vienna, Austria, is recruiting a highly motivated Research Associate interested in cancer therapies and disease biology. The successful candidate will establish new in vivo models to rapidly evaluate novel therapeutic concepts and disease dependencies and will be an integral member of a dynamic and ambitious group of scientists to support cutting-edge basic and biomedical research.
The Obenauf lab is a multidisciplinary group interested in the molecular mechanisms underlying tumor progression and immune evasion. Clinical puzzles inspire our work, and we develop and employ a wide array of molecular biology, biochemistry, and in vivo approaches with the vision and mission of guiding rational combination therapies.
- Training in molecular biology (e.g., Master and/or PhD)
- Willingness to work with animals (mice) is required, experience is a plus
- Experience with tissue culture, FACS (to characterise the immune compartment), and molecular cloning/functional genetics skills is a plus
- Collaborative mindset and motivation to work in an international, interdisciplinary environment
- Team player with strong communication skills and a proactive “getting things done” mentality
- Excellent written and oral communication skills in English (German language skills are not required).
- Develop new models: Generate new experimentally tractable cancer models to investigate complex disease phenotypes and test new therapeutic concepts in ways that would not be feasible in patients.
- Evaluate new drug targets: Asses the effects of (novel) compounds and therapy combinations on tumor growth, metastasis in distinct organs (e.g., brain), the tumor microenvironment, and anti-cancer immune responses.
- Become an integral member of our team: Contribute to cutting-edge cancer research by leading the development of new models and collaborating with our team members. Get involved in additional projects, provide support, and contribute to the team spirit.
The successful candidate will be part of a stimulating research environment at the Vienna BioCenter, a life-science hub in the vibrant city of Vienna, Austria, which is frequently ranked the world’s best city to live in. We provide an unparalleled training opportunity with world-class support at the group-, institute-, and campus-level and closely collaborate with an international network of scientists, clinicians, and industry. The salary is commensurate with qualifications/experience and includes a comprehensive benefits package. While the initial contract will be for one year, we are looking for someone who is willing to contribute to our research long-term.
Applications, including a letter of motivation describing your particular interest in this position and past research experiences, a CV, and the names and contact details of referees, should be submitted online. The application deadline is February 23rd, 2024, but applications are accepted until the position is filled.
Leiendecker et al., Cancer Discovery, 2023; Haas et al. Nature Cancer, 2021; Umkehrer et al., Nature Biotechnology, 2020; Leiendecker et al., EMBO Molecular Medicine, 2020; Obenauf et al., Nature, 2015; Obenauf and Massagué, Nature, 2016; and more to come soon!